← Latest Filings
K
Knotnerus Tim Jasper
Chief Executive Officer
Open-market buys
2
$94K total
Open-market sells
0
$0 total
Tracking since
Oct 2026
Activity timeline
Open-market buy — $44K
AgomAb Therapeutics NV · Oct 6, 2026
Open-market buy — $51K
AgomAb Therapeutics NV · Oct 5, 2026
Open-market trades from the last two years.
Holdings as last reported
34,394 Common shares in AGMB
Held indirectly (By TJK Life Sciences B.V.) · as of 2026-10-05
21,823 Common shares in AGMB
Held directly · as of 2026-10-06
Companies touched
AgomAb Therapeutics NV
CIK 0002020932
